Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlorpromazine 50mg tablets
teva uk ltd - chlorpromazine hydrochloride - oral tablet - 50mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
chlorpromazine 100mg tablets
teva uk ltd - chlorpromazine hydrochloride - oral tablet - 100mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
uniroid hc ointment
essential generics ltd - cinchocaine hydrochloride; hydrocortisone - rectal ointment - 5mg/1gram ; 5mg/1gram
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
uniroid hc suppositories
essential generics ltd - cinchocaine hydrochloride; hydrocortisone - suppository - 5mg ; 5mg
Ayalandi -
Kiingereza -
HPRA (Health Products Regulatory Authority)
posaconazole clonmel 100 mg gastro-resistant tablets
clonmel healthcare ltd - posaconazole - gastro-resistant tablet - 100 milligram(s) - triazole derivatives; posaconazole
Australia -
Kiingereza -
Department of Health (Therapeutic Goods Administration)
posaconazole suspension arx posaconazole 40 mg/ml oral suspension bottle
arrotex pharmaceuticals pty ltd - posaconazole, quantity: 40 mg/ml - oral liquid, suspension - excipient ingredients: sodium benzoate; sodium citrate dihydrate; citric acid monohydrate; titanium dioxide; glycerol; xanthan gum; liquid glucose; peg-40 hydrogenated castor oil; purified water; peg-40 stearate; benzoic acid; glyceryl monostearate; methylcellulose; polysorbate 65; simethicone; sorbic acid; sulfuric acid; flavour - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: ? treatment of oropharyngeal candidiasis in immunocompromised adults, including patients with disease that is refractory to itraconazole and fluconazole. ? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.
Ubelgiji -
Kiingereza -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
genesa solution for infusion
gensia europe - arbutamine - solution for infusion - arbutamine 50 µg/ml - arbutamine
Kenya -
Kiingereza -
Pharmacy and Poisons Board
fezine 500 capsules
medcure healthcare ltd. p.o box 14609- 00400 nairobi. kensia house - cephalexin capsules bp - capsule - cephalexin monohydrate bp- 500 mg - cefalexin
Kenya -
Kiingereza -
Pharmacy and Poisons Board
fezine dry syrup powder for oral suspension
medcure healthcare limited kensia house, muranga road s002 and 15, p.o box - cephalexin bp - powder for oral suspension - cephalexin 125 mg - cefalexin
Kenya -
Kiingereza -
Pharmacy and Poisons Board
fuclear v tablet vaginal tablet
medcure healthcare ltd kensia house muranga road - clotrimazole bp, metronidazole bp, lactobacillus… - vaginal tablet - clotrimazole bp 100 mg metronidazole bp 500 mg… - combinations